Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Current Opinion in Oncology|January 10, 2013
Update on the role of ipilimumab in melanoma and first data on new combination therapiesMichele Maio, Anna M Di Giacomo, Caroline Robert, et al.European Journal of Cancer (Oxford, England : 1990)|June 19, 2022
SARS-CoV-2 infection in cancer patients on active therapy after the booster dose of mRNA vaccinesAnna M Di Giacomo, Gianluca Giacobini, Gabriele Anichini, et al.European Journal of Cancer (Oxford, England : 1990)|December 15, 2022
Immunotherapy for brain metastases and primary brain tumorsAnna M Di Giacomo, Maximilian J Mair, Michele Ceccarelli, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 8, 2022
Brief Communication PD1-related Nephrotoxicity: Optimizing Its Clinical Management Through Histopathologic FeaturesAnna M Di Giacomo, Andrea Guarnieri, Sergio A Tripodi, et al.Cancers|February 3, 2021
No Impact of NRAS Mutation on Features of Primary and Metastatic Melanoma or on Outcomes of Checkpoint Inhibitor Immunotherapy: An Italian Melanoma Intergroup (IMI) StudyMichele Guida, Nicola Bartolomeo, Pietro Quaglino, et al.European Journal of Cancer (Oxford, England : 1990)|August 7, 2023
Italian nivolumab Expanded Access Programme in melanoma adjuvant setting: patient outcomes and safety profilePaolo A Ascierto, Anna M Di Giacomo, Vanna Chiarion Sileni, et al.Expert Opinion on Biological Therapy|February 4, 2020
Prognostic clinical factors in patients affected by non-small-cell lung cancer receiving NivolumabFrancesco Pantano, Marco Russano, Alfredo Berruti, et al.European Journal of Cancer (Oxford, England : 1990)|February 27, 2022
Prognostic and predictive value of β-blockers in the EORTC 1325/KEYNOTE-054 phase III trial of pembrolizumab versus placebo in resected high-risk stage III melanomaOliver J Kennedy, Michal Kicinski, Sara Valpione, et al.Pageof 1